NCT00241423 - Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

exenatide

subcutaneous injection, 5mcg twice a day for one week; then 10 mcg twice a day for one week

DRUG

Placebo

subcutaneous injection, equivalent volume to 5 mcg exenatide twice a day for one week; then equivalent volume to 10 mcg exenatide twice a day for one week

Trial Locations (2)

Unknown

Research Site, Washington D.C.

Research Site, San Antonio